Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia
Sign Up to like & getrecommendations! Published in 2020 at "Trials"
DOI: 10.1186/s13063-020-04912-z
Abstract: Background Sickle cell disease (SCD) is a severe and devastating hematological disorder that affects over 100,000 persons in the USA and millions worldwide. Hydroxyurea is the primary disease-modifying therapy for the SCD, with proven benefits… read more here.
Keywords: trial; hydroxyurea optimization; study; guided dosing ... See more keywords